Fábio Mambelli Silva currently works at the Laboratory of Infectious Diseases at the University of São Paulo and at the Institut Pasteur of São Paulo as a post-doctoral Researcher. He currently works on the development of a recombinant BCG vaccine expressing immunogenic epitopes of N and S proteins as a protective vaccine against COVID-19. He has a PhD/MSc in genetics and a bachelor's in biomedical sciences. He has been an invited professor to teach immunology, biochemistry, genetics, and molecular biology. He conducts research in the biomedical and biotechnological fields, with experience in clinical analyses, molecular genetics, molecular biology, protein biochemistry, and immunology applied to the formulation of vaccine platforms and serological diagnosis. He also has experience with characterizing new molecules of biotechnological interest.